Abstract
Recent advances in nanocarriers for bioactives have focused on finding more sustained-release, natural materials. In this study, genipin-crosslinked soy β-conglycinin (β-CG)-curcumin nanoparticles (G-SCP) significantly enhanced the stability of curcumin and released curcumin controllably in the gastric environment. The optimal intra-particle crosslinkage for G-SCP was obtained under the genipin concentration less than 0.2 mg/mL and stirring at 37 °C for 24 h, which was confirmed by ninhydrin assay, amino acid analysis, dynamic light scattering (DLS) and flourier transform infrared spectroscopy (FT-IR) analysis. Transmission electron microscopy (TEM), DLS and release of trichloroacetic acid (TCA)-soluble nitrogen were used to systematically evaluate the sustained-release behavior and mechanism of curcumin from the G-SCP. The anti-cancer activity of oral-intake curcumin was investigated by collecting the G-SCP digestion supernatant and analyzing its cellular uptake and proliferation in HepG2 cells. The results revealed that the bioaccessible curcumin released from G-SCP had stronger anti-proliferation for HepG2 cells than free curcumin. On normal liver cells L02, interestingly, bioaccessible curcumin had considerably lower cytotoxicity than it did on HepG2 cells. These findings suggested that the G-SCP was a protein-based carrier that could effectively transfer insoluble bioactives in the gastric environment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
